284 related articles for article (PubMed ID: 19917390)
1. Antiretroviral and immunosuppressive drug-drug interactions in human immunodeficiency virus-infected liver and kidney transplant recipients.
Marfo K; Greenstein S
Transplant Proc; 2009 Nov; 41(9):3796-9. PubMed ID: 19917390
[TBL] [Abstract][Full Text] [Related]
2. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ
Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788
[TBL] [Abstract][Full Text] [Related]
3. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
Stock PG; Roland ME; Carlson L; Freise CE; Roberts JP; Hirose R; Terrault NA; Frassetto LA; Palefsky JM; Tomlanovich SJ; Ascher NL
Transplantation; 2003 Jul; 76(2):370-5. PubMed ID: 12883195
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous pancreas-kidney transplantation in HIV-infected patients: a case report and literature review.
Miro JM; Ricart MJ; Trullas JC; Cofan F; Cervera C; Brunet M; Tuset M; Manzardo C; Oppenheimer F; Moreno A
Transplant Proc; 2010 Nov; 42(9):3887-91. PubMed ID: 21094878
[TBL] [Abstract][Full Text] [Related]
5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
6. Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipient.
Barau C; Blouin P; Creput C; Taburet AM; Durrbach A; Furlan V
Fundam Clin Pharmacol; 2009 Aug; 23(4):423-5. PubMed ID: 19709321
[TBL] [Abstract][Full Text] [Related]
7. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
8. [Organ transplants for HIV-infected patients--time for reevaluation?].
Katzenstein TL
Ugeskr Laeger; 2005 Nov; 167(46):4356-8. PubMed ID: 16287518
[TBL] [Abstract][Full Text] [Related]
9. Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients.
Vogel M; Voigt E; Michaelis HC; Sudhop T; Wolff M; Türler A; Sauerbruch T; Rockstroh JK; Spengler U
Liver Transpl; 2004 Jul; 10(7):939-44. PubMed ID: 15237382
[TBL] [Abstract][Full Text] [Related]
10. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
Ortega KL; Vale DA; Magalhães MH
J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation in HIV-infected recipients.
Moreno S; Fortún J; Quereda C; Moreno A; Pérez-Elías MJ; Martín-Dávila P; de Vicente E; Bárcena R; Quijano Y; García M; Nuño J; Martínez A
Liver Transpl; 2005 Jan; 11(1):76-81. PubMed ID: 15690539
[TBL] [Abstract][Full Text] [Related]
12. Solid organ transplantation in HIV-infected recipients.
El Sayegh S; Keller MJ; Huprikar S; Murphy B
Pediatr Transplant; 2004 Jun; 8(3):214-21. PubMed ID: 15176956
[TBL] [Abstract][Full Text] [Related]
13. [Renal transplantation in HIV-infected patients in Spain].
Mazuecos A; Pascual J; Gómez E; Sola E; Cofán F; López F; Puig-Hooper CE; Baltar JM; González-Molina M; Oppenheimer F; Marcén R; Rivero M
Nefrologia; 2006; 26(1):113-20. PubMed ID: 16649432
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation in HIV-infected recipients.
Roland ME; Stock PG
Semin Liver Dis; 2006 Aug; 26(3):273-84. PubMed ID: 16850377
[TBL] [Abstract][Full Text] [Related]
15. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
Neuman MG; Monteiro M; Rehm J
Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation in patients with HIV infection.
Fung J; Eghtesad B; Patel-Tom K; DeVera M; Chapman H; Ragni M
Liver Transpl; 2004 Oct; 10(10 Suppl 2):S39-53. PubMed ID: 15382219
[TBL] [Abstract][Full Text] [Related]
17. Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients.
Jain AB; Venkataramanan R; Eghtesad B; Marcos A; Ragni M; Shapiro R; Rafail AB; Fung JJ
Liver Transpl; 2003 Sep; 9(9):954-60. PubMed ID: 12942457
[TBL] [Abstract][Full Text] [Related]
18. Survival of human immunodeficiency virus-infected liver transplant recipients.
Ragni MV; Belle SH; Im K; Neff G; Roland M; Stock P; Heaton N; Humar A; Fung JF
J Infect Dis; 2003 Nov; 188(10):1412-20. PubMed ID: 14624365
[TBL] [Abstract][Full Text] [Related]
19. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
Neff GW; Bonham A; Tzakis AG; Ragni M; Jayaweera D; Schiff ER; Shakil O; Fung JJ
Liver Transpl; 2003 Mar; 9(3):239-47. PubMed ID: 12619020
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
Kwong GP; Ghani AC; Rode RA; Bartley LM; Cowling BJ; da Silva B; Donnelly CA; van Sighem AI; Cameron DW; Danner SA; de Wolf F; Anderson RM
AIDS; 2006 Oct; 20(15):1941-50. PubMed ID: 16988515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
